People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Other Health Care, Software / Tech, Pharmaceuticals, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Relievant MedSystems Inc | — | Other Health Care | Series C | $200.1M | $523.3M | 2015 |
| Endogastric Solutions Inc | — | Other Health Care | Series C | $177.3M | $557.6M | 2010 |
| Unchained Labs | — | Software / Tech | Series B | $86.0M | $517.4M | 2015 |
| Transposon Therapeutics, Inc. | — | Pharmaceuticals | Series C | $59.1M | $40.6M | 2020 |
| Coaxia Inc | — | Biotechnology | Series B | $40.0M | $893.0M | 2009 |
| Spinifex Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $6.2M | $191.0M | 2014 |
| Nexcida Therapeutics, Inc. | — | Other | Seed | $2.8M | $51.1M | 2015 |
Brent Ahrens at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Brent Ahrens on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Ryan | 1 | 17 |
| Jack Nielsen | 1 | 13 |
| Patrick Heron | 1 | 11 |
| Heath Lukatch | 1 | 10 |
| Denise Barbut | 1 | 9 |
| Michael Burke | 1 | 7 |
| Ross Jaffe | 1 | 7 |
| Chen Yu | 1 | 7 |
| Michael Carusi | 1 | 7 |
| Scott Ward | 1 | 7 |
| William Greene | 1 | 6 |
| Heather Preston | 1 | 6 |
| Justin Klein | 1 | 6 |
| Declan Doogan | 1 | 6 |
| ANTOINE PAPIERNIK | 1 | 6 |
| Dennis Podlesak | 1 | 6 |
| James Bullock | 1 | 6 |
| Uri Geiger | 1 | 6 |
| Lee Wrubel | 1 | 5 |
| B. KRISTINE JOHNSON | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.